Free Delivery Over $100
|
|
|||
|
||||
OverviewAdvances have led to the production of new radiopharmaceuticals and availability of new production routes. Various new diagnostic agents in the field (such as Ga-68 radiopharmaceuticals and generators) as well as therapeutic agents (such as alpha emitters) have been added to the clinician's menu. It is essential that radiopharmaceuticals are prepared within a robust quality control system encompassing materials and personnel, with adequate documentation, and continuous review of ongoing results. This publication provides guidelines and best practices for the quality control of medical radioisotopes and radiopharmaceuticals. It was written by a group of experts with experience across a range of radiopharmaceuticals and is intended to support professionals in the preparation of good quality and safe products to be used in nuclear medicine procedures. Full Product DetailsAuthor: International Atomic Energy AgencyPublisher: IAEA Imprint: IAEA ISBN: 9789201079183ISBN 10: 9201079184 Pages: 148 Publication Date: 30 November 2018 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Temporarily unavailable  The supplier advises that this item is temporarily unavailable. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out to you. Table of ContentsReviewsAuthor InformationThe International Atomic Energy Agency (IAEA) is the world's center of cooperation in the nuclear field. It was set up as the world's Atom's for Peace organization in 1957 within the United Nations family. The Agency works with its Member States and multiple partners worldwide to promote safe, secure and peaceful nuclear technologies. Tab Content 6Author Website:Countries AvailableAll regions |
||||
